Stryker
Orthopedic & Spine Implants · Surgical Instruments & Devices

Stryker: Ownership & structure

Stryker operates through 8 legal entities in 7 countries.

Data updated Nov 21, 2026 · Back to the company report

Owners & entities

Stryker operates through 8 legal entities in 7 countries.

Legal entities8 in 7 countries
operator · US EIN 381239739 · LEI 5493002F0SC4JTBU5137
US
STRYKER AB
subsidiary
NO
subsidiary · IE CRO 631711
IE
4 more records: legal entities with their register numbers and links to each registerProUnlockor this company alone for 30 days · 50 credits
Subsidiaries in its annual report: 191 in 54 jurisdictions · USA - Delaware 40, Netherlands 19, Germany 13, Ireland 12, France 12 · sec.gov ↗
Stakes and purchases
ownership of shares 75 to 100 percent; voting rights 75 to 100 percent; right to appoint and remove directors
75%
Large holders (13D / 13G)holders of 5% or more, their newest filing
an individual investor
active holder · SCHEDULE 13D/A · Apr 2026
4%
VANGUARD CAPITAL MANAGEMENT LLC
passive holder · SCHEDULE 13G · Apr 2026
VANGUARD GROUP INC
passive holder · SCHEDULE 13G/A · Mar 2026
GREENLEAF TRUST
passive holder · SCHEDULE 13G/A · Feb 2026
Insider tradesopen-market buys and sales on SEC Form 4, last 12 months

Insiders bought $0 (0 people) and sold $400.8M (6 people) in the last 12 months.

Sold · Group President
441 shares at $328.61 · Aug 2026
$145k
Sold · Director
16,612 shares at $340.71 · Aug 2026
$5.7M
Sold · Director
11,257 shares at $338.90 · Aug 2026
$3.8M
Sold · Director
10,812 shares at $339.71 · Aug 2026
$3.7M
Sold · Director
3,852 shares at $342.80 · Aug 2026
$1.3M
Sold · Director
3,274 shares at $341.84 · Aug 2026
$1.1M
Sold · Director
2,308 shares at $337.98 · Aug 2026
$780k
Sold · Director
805 shares at $343.47 · Aug 2026
$276k
Sold · Director
440 shares at $333.18 · Aug 2026
$147k
Sold · Director
320 shares at $336.79 · Aug 2026
$108k
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
Lumira VenturesVia a fund
55 portfolio companies: X4 Pharmaceuticals, Organiq Media, XyloCor and 52 more
NEAVia a fund
672 portfolio companies